Grey Street Capital »

Teva Pharmaceutical Industries shares owned by Grey Street Capital

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 131k 10.44
2023-09-30 $1.3M 131k 10.20
2023-06-30 $986k 131k 7.53
2023-03-31 $1.2M 131k 8.85

More positions owned by Grey Street Capital

Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Accenture Plc Ireland Shs Class A (ACN)
Amazon (AMZN)
Adobe Systems Incorporated (ADBE)
Agnico (AEM)
Alamos Gold Com Cl A (AGI)
Goldman Sachs (GS)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Cable One (CABO)
Crowdstrike Hldgs Cl A (CRWD)
Block Cl A (SQ)
Equity Lifestyle Properties (ELS)

View all positions for Grey Street Capital

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership
Sphera Funds Management

View all funds holding Teva Pharmaceutical Industries